niacinamide has been researched along with Ventricular Dysfunction in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is associated with adverse cardiac effects, including left ventricular dysfunction." | 7.81 | Downregulation of stanniocalcin 1 is responsible for sorafenib-induced cardiotoxicity. ( Kawabata, M; Kuroyanagi, J; Miyabe, M; Nishimura, Y; Shimada, Y; Tanaka, T; Umemoto, N; Zhang, B, 2015) |
| "Sorafenib is associated with adverse cardiac effects, including left ventricular dysfunction." | 3.81 | Downregulation of stanniocalcin 1 is responsible for sorafenib-induced cardiotoxicity. ( Kawabata, M; Kuroyanagi, J; Miyabe, M; Nishimura, Y; Shimada, Y; Tanaka, T; Umemoto, N; Zhang, B, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grieco, A | 1 |
| Lombardo, A | 1 |
| Biolato, M | 1 |
| Kawabata, M | 1 |
| Umemoto, N | 1 |
| Shimada, Y | 1 |
| Nishimura, Y | 1 |
| Zhang, B | 1 |
| Kuroyanagi, J | 1 |
| Miyabe, M | 1 |
| Tanaka, T | 1 |
| López, JR | 1 |
| Jahangir, R | 1 |
| Jahangir, A | 1 |
| Shen, WK | 1 |
| Terzic, A | 1 |
3 other studies available for niacinamide and Ventricular Dysfunction
| Article | Year |
|---|---|
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Heart Diseases; | 2013 |
Downregulation of stanniocalcin 1 is responsible for sorafenib-induced cardiotoxicity.
Topics: Adult; Animals; Antineoplastic Agents; Cardiotoxicity; Down-Regulation; Glycoproteins; Heart; Humans | 2015 |
Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia.
Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Calcium; Calcium Channel Blockers; Cardioplegic | 1996 |